Luigia Valsecchi^1*, Simone Naso^1*, Simona Procopio^1*, Mario Mauri, PhD^2*, Rocco Piazza, MD, PhD^2*, Titus Watrin^3*, Sanil Bhatia, PhD^3*, Valentina Pasquale, PhD^4*, Elena Sacco, PhD^4*, Chiara Palmi, PhD^1*, Grazia Fazio, PhD^1*, Luca Trentin, PhD^5*, Silvia Bresolin, PhD^5*, Andrea Biondi, MD, PhD^1,6, Giovanni Cazzaniga, PhD^1,7 and Michela Bardini, PhD^1*

¹Tettamanti Research Center, Pediatrics, Department of Medicine, University of Milano-Bicocca, Monza, Italy
²Hematology, Department of Medicine, University of Milano-Bicocca, Monza, Italy
³Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, Duesseldorf, Germany
⁴Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milano, Italy
⁵SDB Department, Pediatric Hemato-Oncology, University of Padova, Padova, Italy
⁶Pediatrics, Department of Medicine, University of Milan Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
⁷Medical Genetics, Department of Medicine, University of Milano-Bicocca, Monza, Italy

Domingo Domenech Eva, MD^1,2*, Fina Climent, PhD^3*, Eva Gonzalez Barca, MD, PhD^4,5*, Eugenia de Lama, MD^6*, Maria Martinez Iniesta^7*, Monica Calaf^8*, Clara Montane, MD^9*, Ana C Oliveira, MD, PhD^10*, Patricia Lopez, MD^11*, Gabriela Sanz-Linares, MD^11*, Esmeralda de la Banda, MD^12*, Laura Arregui^13*, Villanueva Alberto, PhD^7*, Anna Sureda¹⁴ and Lourdes Farre, PhD^15*

¹Department of Hematology, Institut Catala d’Oncologia. Hospital Duran i Reynals. IDIBELL, Barcelona, Barcelona, Spain
²Hematology Department, Institut Catala d'Oncologia. Hospital Duran i Reynals. IDIBELL, Hospitalet de Llobregat, Spain
³Pathology Department, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet De Llobregat, Spain
⁴Hospital Duran i Reynals, INSTITUT CATALA D'ONCOLOGIA, BARCELONA, ESP
⁵Departament de Ciencies Cliniques, Universitat de Barcelona., Barcelona, Spain
⁶Radiology Department. Hospital Universitari de Bellvitge. IDIBELL, Hospitalet de Llobregat, Spain
⁷Group of Chemoresistance and Predictive Factors, Subprogram Against Cancer Therapeutic Resistance, Catalan Institute of Oncology, Oncobell Program, IDIBELL., Hospitalet de Llobregat, Spain
⁸Group of Chemoresistance and Predictive Factors, Subprogram Against Cancer Therapeutic Resistance, Catalan Institute of Oncology, Oncobell Program, IDIBELL., L'Hospitalet De Llobregat, ESP
⁹Hematology Department. Institut Catala d'Oncologia. Hospital Duran i Reynals. IDIBELL, Hospitalet de Llobregat, Spain
¹⁰Department of Clinical Hematology, Institut Català d’Oncologia – Hospital Duran I Reynals, IDIBELL, Barcelona, Spain
¹¹Department of Clinical Hematology. Institut Catala d'Oncologia. Hospital Duran i Reynals. IDIBELL, Hospitalet de Llobregat, Spain
¹²Department of Pathology. Hospital Universitari de Bellvitge. IDIBELL., Hospitalet de Llobregat, Spain
¹³BIOBANK HUB-ICO-IDIBELL, Hospitalet de Llobregat, Spain
¹⁴Institut Català d'Oncologia - Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain
¹⁵Group of Chemoresistance and Predictive Factors, Subprogram Against Cancer Therapeutic Resistance, Catalan Institute of Oncology, Oncobell Program, IDIBELL., L'Hospitalet De Llobregat, Barcelona, ESP

Natalia Baran, MD, PhD¹, Shraddha Patel, MS^2*, Cassandra L Ramage^3*, Alessia Lodi, PhD^4*, Jose Enriquez Ortiz, PhD^5*, Yogesh Dhungana, PhD^6*, Meghan Collins, BS⁷, Anna Skwarska, PhD^1*, Connie Weng, BA^1*, Kala Hayes^1*, Zhihong Zeng, MD^8*, Laurie Cooper, BSc^9*, Richard Eric Davis, MD^10*, Gheath Alatrash, PhD, DO¹¹, Joseph R Marszalek, PhD^12*, Jiyang Yu, Ph.D.^13*, Pratip K Bhattacharya, PhD^5*, Stefano Tiziani^14* and Marina Konopleva, MD, PhD^15,16

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX
⁴Dell Pediatric Research Institute, Dell Medical School, The University of Texas at Austin, Austin, TX
⁵Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN
⁷University of Texas At Austin, Austin, TX
⁸MD Anderson Cancer Center, Houston, TX
⁹The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹²Institute for Applied Cancer Science & Center for Co-Clinical Trials, The University of Texas MD Anderson Cancer Center, Houston, TX
¹³Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN
¹⁴Department of Nutritional Sciences & Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX
¹⁵MD Anderson Cancer Center, Houston, TX
¹⁶Albert Einstein College of Medicine, Bronx, NY

Mengfei Ding^1*, Zhuoya Yu^1*, Yiqing Cai^1*, Tiange Lu^1*, Xiaomin Chen^1*, Xiangxiang Zhou^1,2* and Xin Wang^1,2

¹Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China
²Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

Weiyuan Wang, PhD^1,2*, Foster Burton^2*, Sylvia Herter, PhD^3*, Laura Codarri Deak, PhD^3*, Christian Klein, PhD³ and David Frank, MD, PhD^1,2

¹Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
²Dana-Farber Cancer Institute, Boston, MA
³Roche Innovation Center Zurich, Schlieren, Switzerland

Curtis J Henry, PhD¹, Miyoung Lee, PhD^2* and Aleksandra Filipovic, MD PhD^3*

¹Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
²Emory University, Atlanta, GA
³PureTech Health, Boston, MA

Brennan P. Bergeron, MS^1,2*, Jonathan D. Diedrich, PhD^2,3*, Yang Zhang, PhD^4*, Kelly R. Barnett, PhD^2,3*, Qian Dong, PhD^3*, Daniel Ferguson, PhD^3*, Robert J Autry^3*, Wenjian Yang, PhD^2,3*, Baranda S Hansen^5*, Colton A Smith^6*, Kristine R. Crews, PharmD^2,3*, Yiping Fan, PhD^7*, Ching-Hon Pui, MD^2,8, Shondra Miller^5,9*, Mary V. Relling, PharmD^2,3, Jun J. Yang, PhD^2,6, Chunliang Li, PhD¹⁰, William E. Evans, PharmD^2,3 and Daniel Savic, PhD^1,2,3

¹Graduate School of Biomedical Sciences, St. Jude Children's Research Hospital, Memphis, TN
²Hematological Malignancies Program and Center for Precision Medicine in Leukemia, St. Jude Children's Research Hospital, Memphis, TN
³Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
⁴Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, TN
⁵Center for Advanced Genome Engineering (CAGE), St Jude Children's Research Hospital, Memphis, TN
⁶Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN
⁷Center for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN
⁸Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
⁹Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN
¹⁰St. Jude Children's Research Hospital, Memphis, TN

Satoshi Yoshimura, MD^1*, Jianzhong Hu, PhD^1*, John C. Panetta, PhD^1*, Guoqing Du^1*, Lie Li^1*, Ching-Hon Pui, MD², Marina Konopleva, MD, PhD³, Nitin Jain, MD⁴ and Jun J. J. Yang, PhD^1,5

¹Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN
²Department of Oncology, St. Jude Children's Rsch./Hosp., Memphis, TN
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁵Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN

Fen Zhu, PhD, Christine E. Ryan, MD, Liam R. Hackett, AB^*, Mary C Collins, BS^*, Stephen Jun Fei Chong, PhD and Matthew S. Davids, MD

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Paola Manara, BS, MS^1*, Tyler A. Cunningham, BS^1*, J.J. David Ho, PhD^2*, Caroline A. Coughlin, BS¹ and Jonathan H. Schatz, MD^1,3

¹University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
²Hexagon Bio, Menlo Park, CA
³Division of Hematology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL

Edoardo Pennesi^1,2*, Erica Brivio, MD^1,2*, Kathleen B. Pelletier^3*, Ying Chen^4*, Alwin D. R. Huitema^2,5,6*, Yilin Jiang, MSc^2*, Anneke C. J. Ammerlaan^1,2*, Barbara Sleight, MD^3*, Franco Locatelli, MD⁷, Inge M. Van Der Sluis, MD, PhD², Claudia Rossig^8*, Christiane Chen-Santel, MD^9*, Bella Bielorai, MD^10*, Arnaud Petit, MD, PhD^11*, Jan Stary, MD^12*, Lucie Sramkova, MD^12*, Cristina Díaz de Heredia Rubio, MD^13*, Susana Rives^14*, Aengus O'Marcaigh, MD^15*, Carmelo Rizzari, MD^16*, Gernot Engstler, MD^17*, Karsten Nysom, MD, PhD^18*, Alba Rubio-San-Simón^19*, Francisco J. Bautista Sirvent^2*, Bénédicte Bruno, MD^20*, Yives Bertrand, MD^21*, Benoit Brethon, MD^22*, Fanny Rialland, MD^23*, Genevieve Plat^24*, Uta Dirksen^25*, May Garrett^26* and Christian M. Zwaan, Prof, MD, PhD^1,2*

¹Department of Pediatric Oncology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, Netherlands
²Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
³Pfizer Inc, Groton, CT
⁴Pfizer Inc, La Jolla, CA
⁵University Medical Center Utrecht, Utrecht, Netherlands
⁶The Netherlands Cancer Institute, Amsterdam, Netherlands
⁷IRCCS Ospedale Pediatrico Bambino Gesú, Catholic University of the Sacred Heart, Rome, Italy
⁸Department of Pediatric Hematology and Oncology, University Children's Hospital Münster, Münster, Germany
⁹Rostock Medical Center, Rostock, Germany
¹⁰Division of Pediatric Hematology and Oncology, Sheba Medical Center, Ramat-Gan, Israel
¹¹Pediatric Hematology and Oncology Department, Trousseau Hospital, Hopital Armand Trousseau, APHP, Sorbonne Université, Paris, France
¹²Department of Pediatric Hematology and Oncology, University Hospital Motol, Prague, Czech Republic
¹³Division of Pediatric Hematology and Oncology, Hospital Universitario Vall d´Hebron, Barcelona, Spain
¹⁴Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu de Barcelona, Barcelona, Spain
¹⁵The Hospital for Sick Children, Dublin, IRL
¹⁶Pediatric Hematology-Oncology Unit, University of Milano-Bicocca, MBBM Foundation, San Gerardo Hospital, Monza, Italy
¹⁷St Anna Children's Hospital, Medical University of Vienna, Vienna, Austria
¹⁸Department of Paediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark
¹⁹Department of Pediatric Oncology and Hematology, Hospital Niño Jesús, Madrid, Spain
²⁰Pediatric Hematology, Hôpital Jeanne de Flandre, CHRU de Lille, Lille, France
²¹Institute of Pediatric Hematology and Oncology, Civil Hospital of Lyon - Claude Bernard University, Lyon, France
²²Department of Pediatric Hematology and Immunology, Robert-Debré Hospital, AP-HP, University of Paris, Paris, France
²³Service Onco-Hématologie Pédiatrique, Hôpital Mère-Enfant, Nantes University Hospital, Nantes, France
²⁴Service d’Hématologie-Immunologie-Oncologie, Hôpital des Enfants - CHU Toulouse, Toulouse, France
²⁵Pediatrics III, West German Cancer Center, German Cancer Consortium (DKTK), Essen University Hospital, Essen, Germany
²⁶Pfizer Oncology, La Jolla, CA

Ipsita Pal, PhD^1,2*, Anuradha Illendula, PhD^3*, John Sanil Manavalan, MD^2,4*, Todd P Fox, PhD^3*, Owen A. O'Connor, MD, PhD^1,2, Thomas P. Loughran Jr., MD^2,4, Mark Kester, PhD^3,5*, David J Feith, PhD^2,4* and Enrica Marchi, MD, PhD^1,2

¹Program for T-Cell Lymphoma Research, University of Virginia, Charlottesville, VA
²University of Virginia Cancer Center, University of Virginia, Charlottesville, VA
³Department of Pharmacology, University of Virginia, Charlottesville, VA
⁴Division of Hematology & Oncology, Department of Medicine, University of Virginia, Charlottesville, VA
⁵Department of Pharmacology, Biomedical Engineering, Molecular Physiology and Biophysics, University of Virginia, Charlottesville, VA

Kevin Bowman^1*, Cory Mavis, MSc^2*, Taylor K Mandeville, BA^3*, Noah Lemoine, BS^4*, Juan Gu, PhD, MD^5* and Francisco Hernandez-Ilizaliturri, MD⁶

¹Roswell Park Comprehensive Cancer center, Buffalo
²Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
³Department of Immunology, Roswell Park Comprehensive Cancer Center, Graduate Division of State University of New York at Buffalo, Buffalo, NY
⁴Roswell Park Comprehensive Cancer Center, Buffalo
⁵Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁶Roswell Park Cancer Institute, Buffalo, NY

Aimee Merino, MD PhD¹, Hayden Hamsher^2*, Daniel Mansour^2*, Gregory I. Berk, MD³, Martin Felices, PhD^4* and Jeffrey S. Miller, MD, MD⁴

¹Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
²University of Minnesota, Minneapolis
³GT BioPharma, Inc., Brisbane, CA
⁴Masonic Cancer Center, University of Minnesota, Minneapolis, MN

Ting DU, PhD^1*, Xueping Wan^1*, Arghya Ray, PhD¹, Yao Yao^1*, Ruben D. Carrasco, MD, PhD^2,3*, Mariateresa Fulciniti, PhD¹, Nikhil C Munshi, MD, PhD^1,4, Dharminder Chauhan, PhD^1* and Kenneth C. Anderson, MD¹

¹Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²Department of Pathology, Brigham and Women's Hospital, Boston, MA
³Department of Pathology, Dana-Farber Cancer Institute, Boston, MA
⁴Veterans Administration Boston Healthcare System, West Roxbury, MA

Min Zhu, PhD^1*, Michael Dodds, PhD^2*, Srikanth R. Ambati, MBBS, MD^1*, Hesham Mohamed, MD^1*, Jason Chittenden, PhD^1*, Hong Yan^1*, Aafia Chaudhry, MD, MBA, MS^1* and John D. Davis, BPharm, PhD^1*

¹Regeneron Pharmaceuticals, Inc., Tarrytown, NY
²Certara, Princeton, NJ

Yuqin Song, MD¹, Ning Ding, MD^1*, Dok Hyun Yoon^2*, John C. Reneau, MD, PhD³, Ryan A. Wilcox, MD, PhD⁴, Won Seog Kim, MD^5*, Youn H. Kim, MD⁶, Michael S. Khodadoust, MD PhD⁶, Tatyana A. Feldman, MD⁷, Costas K. Yannakou, MBBS^8*, Pratyush Giri, MBBS^9*, Jonathan E Brammer, MD³, Lih-Yun Hsu, PhD^10*, Hongwei Yuan, PhD^10*, Erik Verner, PhD^11*, Suresh Mahabhashyam, MD^10* and Richard A. Miller, MD^10,11

¹Peking University Cancer Hospital & Institute, Beijing, China
²Asan Medical Center, Seoul, Korea, Republic of (South)
³The Ohio State University and Wexner Medical Center, Columbus, OH
⁴University of Michigan, Ann Arbor, MI
⁵Samsung Medical Center, Seoul, Korea, Republic of (South)
⁶Stanford Cancer Institute, Stanford, CA
⁷John Theurer Cancer Center at HMH, Hackensack, NJ
⁸Epworth HealthCare, Melbourne, VIC, Australia
⁹Royal Adelaide Hospital, Adelaide, SA, Australia
¹⁰Corvus Pharmaceuticals, Inc., Burlingame, CA
¹¹Angel Pharmaceuticals Co., Ltd, Jiaxing, China

Zhongying Mo^1*, Lynda Groocock^1*, Scott Wood^1*, Diana Jankeel^1*, Preethi Janardhanan^1*, Derek Mendy^1*, Michael Angelo^1*, In Sock Jang^2*, Celia Fontanillo^3*, Kai Wang^2*, Mark Rolfe¹ and Antonia Lopez-Girona^1*

¹Oncogenesis Thematic Research Center, Bristol Myers Squibb, San Diego, CA
²Predictive Sciences, Bristol Myers Squibb, San Diego, CA
³Bristol Myers Squibb, Princeton, NJ

Andre M. Grilo, PhD^1*, Christine Klaus, BS^2*, Alice McDonald, PhD^2*, Jared Gollob, M.D.^2*, Matt Weiss, PhD^2*, Owen A. O'Connor, MD, PhD³, Gilles Salles, MD, PhD¹, Jayanta Chaudhuri^4* and Jennifer Kimberly Lue, MD¹

¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Kymera Therapeutics, Watertown, MA
³Program for T-Cell Lymphoma Research, University of Virginia, Charlottesville, VA
⁴Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY

Daniela Y Santiesteban, PhD^1*, Aundrietta D Duncan, PhD^1*, Nadeem Q Mirza, MBBS, MPH^1*, Vincent Jacques, PhD^1,2*, Sheila DeWitt, PhD^1,2* and Swami P. Iyer, MD³

¹Salarius Pharmaceuticals, Inc., Houston, TX
²DeuteRx, LLC, Andover, MA
³Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Saeed Daneshmandi, PhD^1*, Cameron R. MacDonald, BS^1*, Manu Pandey, MBBS², Jee Eun Choi, BS^1*, Nathan Roberts, MD¹, Suzanne M Hess, PhD^3*, Teresa W.M. Fan, PhD^4*, Richard M. Higashi, PhD^4*, Andrew N. Lane, PhD^4*, Prashant Singh, PhD^5*, Jianmin Wang, PhD^6*, Philip L. McCarthy, MD⁷, Elizabeth A. Repasky, PhD^1* and Hemn Mohammadpour, PhD⁸

¹Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
²Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
³Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁴Department of Toxicology and Cancer Biology, Markey Cancer Center, Center for Environmental and Systems Biochemistry, Lexington, KY
⁵Department of Cancer Genetics & Genomics, Roswell Park Cancer Comprehensive Cancer Center, Buffalo, NY
⁶Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁷Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁸Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Kailen Mark^1*, Marilee Robbins, BS^1*, Anna Gamble, MD^1*, Hee-Don Chae, PhD^1*, Michael Bassik, PhD^2*, Kyuho Han, PhD^2* and Kathleen M. Sakamoto, MD, PhD¹

¹Department of Pediatrics, Stanford University, Stanford, CA
²Department of Genetics, Stanford University, Stanford, CA

Alexandria P Eiken, BS, Sydney A Skupa, BS^*, Neecole Brown^*, Audrey L Smith, BS, Sarbjit Singh, PhD^*, Sandeep Rana, PhD^*, Amarnath Natarajan, PhD^* and Dalia ElGamal, MSc, PhD

Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, NE

Daisuke Morishita, PhD^1*, Akio Mizutani, PhD^1*, Hiroko Yamakawa^1*, Yasuyoshi Arikawa, PhD^1*, Hirokazu Tozaki, PhD^1*, Takuro Kameda, MD, PhD², Ayako Kamiunten, MD^2*, Keisuke Kataoka, MD, PhD^3,4, Akinori Yoda, PhD^5*, Yotaro Ochi, MD, PhD^5*, Kotaro Shide, MD, PhD², Koji Izutsu, MD, PhD⁶, Yosuke Minami, MD, PhD⁷, Kazuya Shimoda, MD, PhD² and Seishi Ogawa, MD, PhD⁵

¹Chordia Therapeutics Inc., Fujisawa, Kanagawa, Japan
²Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
³Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan
⁴Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
⁵Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto City, Japan
⁶Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
⁷National Cancer Center Hospital East, Kashiwa, Japan

Jillian Simard, MD¹, Cody Peer, PhD^2*, Rahul Lakhotia, MBBS¹, Christopher Melani, MD¹, Amynah Pradhan, CRNP-F^1*, Andrea Nicole Lucas, RN^1*, William D. Figg, PhD^2*, Wyndham H. Wilson, MD, PhD¹ and Mark Roschewski, MD¹

¹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

Isharat Yusuf^*, Marcos W Steinberg^*, Maricel Gozo^*, Bryan Clemons^*, Kay Hou^*, David Guimond^*, Mark J Rose^*, Kristen Taylor Meadows^* and Laura Carter^*

Gossamer Bio, Inc., San Diego, CA